Onecare Biotechnologies Market study

This project will support OneCare Biotechnologies, a Canadian startup developing a blood-based diagnostic test to guide treatment decisions for individuals with psychotic disorders such as schizophrenia. These conditions are often misdiagnosed or inappropriately treated, leading to poorer health outcomes and higher healthcare costs. While OneCare has made strong progress in developing its technology, it now faces key business challenges, including identifying its target customers, setting an effective pricing strategy, and navigating reimbursement pathways. Through a structured market study focused on Canada and the United States, this project will provide insights into market needs, competitive positioning, and regulatory considerations. The findings will help OneCare create a clear and evidence-based commercialization plan to bring its innovation to market and improve mental health care delivery.

Faculty Supervisor:

Aleksi Eerola

Student:

Partner:

OneCare Biotechnologies

Discipline:

Sociology

Sector:

Professional, scientific and technical services

University:

HEC Montréal

Program: